Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FY3UE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $96,979
Award facts
- Contract value 100% obligated
- $96,979.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $96,979.40 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic inflammatory conditions, making this procurement essential for military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems globally. AmerisourceBergen's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its established capacity to meet federal pharmaceutical procurement requirements through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FY3UE?
SPE2DB25FY3UE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FY3UE worth?
The government has obligated $96,979 on SPE2DB25FY3UE.
Is contract SPE2DB25FY3UE an order under another contract?
Yes. SPE2DB25FY3UE is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY3UE competed?
The extent of competition for SPE2DB25FY3UE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award